Human Genetic as Risk Factors for COVID-19 Progression DOI Creative Commons

Mohamed Hosney,

Radwa Sallam,

Mariam Sayed

et al.

Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology/Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology, Journal Year: 2023, Volume and Issue: 15(2), P. 529 - 561

Published: Oct. 29, 2023

Background: Thousands of people have already died as a result the 2019 coronavirus disease pandemic (COVID-19), which was brought on by SARS-CoV-2 coronavirus.There were many unimaginable cases illness in Washington 2020 first case, and then it transmitted to Wuhan, Germany, France, Italy, Spain, United Kingdom China.The newly discovered SARS-CoV, MERS-CoV, are believed be natural not laboratory synthetic.The COVID-19 may due contamination infected objects with materials that spread across world.Main body: Human infection symptoms can range from being asymptomatic fatal, including respiratory failure, multiple organ dysfunction, death.Large-scale genetic association studies demonstrated immune system components such interferons, interleukins, toll-like receptors, human leukocyte antigen well receptor variations (angiotensinconverting enzymes, transmembrane serine protease-2) important host determinants severity.Conclusion: The current review aims demonstrate factors affect severity.

Language: Английский

Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update DOI

Sizhen Su,

Yi‐Miao Zhao, Na Zeng

et al.

Molecular Psychiatry, Journal Year: 2023, Volume and Issue: 28(10), P. 4056 - 4069

Published: July 25, 2023

Language: Английский

Citations

64

Long term neuropsychiatric consequences in COVID-19 survivors: Cognitive impairment and inflammatory underpinnings fifteen months after discharge DOI
Danmei He, Minlan Yuan, Wen Dang

et al.

Asian Journal of Psychiatry, Journal Year: 2022, Volume and Issue: 80, P. 103409 - 103409

Published: Dec. 15, 2022

Language: Английский

Citations

40

Cognitive impairment in long-COVID and its association with persistent dysregulation in inflammatory markers DOI Creative Commons
Rodolfo Furlan Damiano, Cristiana Castanho de Almeida Rocca, Antônio de Pádua Serafim

et al.

Frontiers in Immunology, Journal Year: 2023, Volume and Issue: 14

Published: May 23, 2023

To analyze the potential impact of sociodemographic, clinical and biological factors on long-term cognitive outcome patients who survived moderate severe forms COVID-19.We assessed 710 adult participants (Mean age = 55 ± 14; 48.3% were female) 6 to 11 months after hospital discharge with a complete battery, as well psychiatric, laboratory evaluation. A large set inferential statistical methods was used predict variables associated any impairment, focus panel 28 cytokines other blood inflammatory disease severity markers.Concerning subjective assessment performance, 36.1% reported slightly poorer overall 14.6% being severely impacted, compared their pre-COVID-19 status. Multivariate analysis found sex, age, ethnicity, education, comorbidity, frailty physical activity general cognition. bivariate that G-CSF, IFN-alfa2, IL13, IL15, IL1.RA, EL1.alfa, IL45, IL5, IL6, IL7, TNF-Beta, VEGF, Follow-up C-Reactive Protein, D-Dimer significantly (p<.05) However, LASSO regression included all follow-up variables, markers did not support these findings.Though we identified several sociodemographic characteristics might protect against impairment following SARS-CoV-2 infection, our data do prominent role for status (both during acute long-stage COVID-19) or background (also explain deficits can follow COVID-19 infection.

Language: Английский

Citations

26

Interplay between Comorbidities and Long COVID: Challenges and Multidisciplinary Approaches DOI Creative Commons
Rasha Ashmawy, Esraa Abdellatif Hammouda, Yousra A. El‐Maradny

et al.

Biomolecules, Journal Year: 2024, Volume and Issue: 14(7), P. 835 - 835

Published: July 11, 2024

Long COVID, a name often given to the persistent symptoms following acute SARS-CoV-2 infection, poses multifaceted challenge for health. This review explores intrinsic relationship between comorbidities and autoimmune responses in shaping trajectory of long COVID. Autoantibodies have emerged as significant players COVID-19 pathophysiology, with implications disease severity progression. Studies show immune dysregulation persisting months after marked by activated innate cells high cytokine levels. The presence autoantibodies against various autoantigens suggests their potential comorbid factors Additionally, formation complexes may lead severe progression, highlighting urgency early detection intervention. Furthermore, COVID is highly linked cardiovascular complications neurological symptoms, posing challenges diagnosis management. Multidisciplinary approaches, including vaccination, tailored rehabilitation, pharmacological interventions, are used mitigating COVID’s burden. However, numerous persist, from evolving diagnostic criteria addressing psychosocial impact predicting outcomes. Leveraging AI-based applications holds promise enhancing patient management improving our understanding As research continues unfold, unravelling complexities remains paramount effective intervention care.

Language: Английский

Citations

11

Cognitive profile, neuroimaging and fluid biomarkers in post-acute COVID-19 syndrome DOI Creative Commons
Núria Guillén, Agnès Pérez‐Millan, Neus Falgàs

et al.

Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)

Published: June 5, 2024

Abstract We aimed to characterize the cognitive profile of post-acute COVID-19 syndrome (PACS) patients with complaints, exploring influence biological and psychological factors. Participants confirmed SARS-CoV-2 infection complaints ≥ 8 weeks phase were included. A comprehensive neuropsychological battery (NPS) health questionnaires administered at inclusion 1, 3 6 months. Blood samples collected each visit, MRI scan baseline months, and, optionally, cerebrospinal fluid. Cognitive features analyzed in relation clinical, neuroimaging, biochemical markers follow-up. Forty-nine participants, a mean time from symptom onset 10.4 showed attention-executive function (69%) verbal memory (39%) impairment. Apathy (64%), moderate-severe anxiety (57%), severe fatigue (35%) prevalent. Visual (8%) correlated total gray matter (GM) subcortical GM volume. Neuronal damage inflammation within normal limits. Over time, test scores, depression, apathy, indexes, fluid biomarkers remained stable, although fewer participants (50% vs. 75.5%; p = 0.012) exhibited abnormal evaluations Altered attention/executive memory, common PACS, persisted most subjects without association structural abnormalities, elevated cytokines, or neuronal markers.

Language: Английский

Citations

5

Neurofilament light chain as a biomarker for neurodegenerative changes in COVID-19 and clinical implications DOI
Yousef Rasmi,

Yeganeh Farnamian,

Marijana Marković Boras

et al.

Future Virology, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 15

Published: March 21, 2025

Language: Английский

Citations

0

Identification and prioritisation of biomarkers of organophosphorus compounds-induced neurotoxicity DOI Creative Commons
Antonio F. Hernández, Marina Lacasaña,

Helena Garcia-Cortés

et al.

Environment International, Journal Year: 2025, Volume and Issue: unknown, P. 109446 - 109446

Published: April 1, 2025

Organophosphorus compounds (OPCs), a diverse group of chemicals widely utilised as pesticides and flame retardants, pose significant neurotoxic risks, even during neurodevelopment. While their primary molecular cellular targets are well characterised, growing evidence suggest additional mechanisms, particularly in developmental neurotoxicity. Despite extensive research, predictive biomarkers OPC-induced neurotoxicity beyond acetylcholinesterase remain underexplored. This study conducted comprehensive review epidemiological, vivo, vitro to identify prioritise associated with Findings highlight the critical roles non-cholinergic including neuroinflammation, mitochondrial dysfunction, oxidative stress, epigenetic modifications. Biomarkers were categorised based on biological function, mechanistic relevance, feasibility for early, non-invasive detection. Current research efforts focus validating sensitive reliable capable predicting monitoring nervous system damage severity. Growing attention is being directed toward that correlate behavioural, neuropathological, imaging outcomes. addresses two main aspects. The first provides an overview established emerging assessing general population individuals occupationally exposed OPC. second evaluates prioritised scientific robustness, clinical regulatory applicability. A structured ranking across different levels organisation proposed enhance understanding improve risk assessment. underscores need standardised biomarker framework assessment decision-making. Implementing these biomonitoring purposes will facilitate early detection prevention strategies, ultimately mitigating effects individuals.

Language: Английский

Citations

0

Self-reported health, neuropsychological tests and biomarkers in fully recovered COVID-19 patients vs patients with post-COVID cognitive symptoms: A pilot study DOI Creative Commons
Michael Lawrence, Judith E. Arnetz, Scott Counts

et al.

PLoS ONE, Journal Year: 2025, Volume and Issue: 20(5), P. e0315486 - e0315486

Published: May 15, 2025

Substantial numbers of individuals who contract COVID-19 experience long-lasting cognitive symptoms such as brain fog. Yet research to date has not compared these patients with healthy controls a history laboratory-confirmed infection, making it difficult understand why certain COVID develop post-COVID while others do not. The objective this pilot study was compare two groups patients, and without symptoms, on measures psychological functioning, self-reported perceptions functional status quality life, biomarkers stress, inflammation, neuroplasticity. Using case-control design, 17 participants were recruited from healthcare system in western Michigan, USA 2022–2024. All aged 25–65 had positive polymerase chain reaction (PCR) test confirming previous infection. Ten reported (long group) seven fully recovered no residual (controls). underwent an interview their self-rated health battery neurocognitive tests, blood draw for biomarker analysis. No group differences detected neuropsychological except letter fluency where the long scored significantly lower (p < .05). ratings than physical health, emotional well-being. Serum levels nerve growth factor (NGF), plasticity, group, which more likely have serum inflammatory marker (interleukin (IL)-10) values greater or equal median = 0.015). Biomarker analyses suggest possible prolonged processes patients. Results decreased neuroplastic functioning give credence patients’ reports changes function.

Language: Английский

Citations

0

Promising Markers of Inflammatory and Gut Dysbiosis in Patients with Post-COVID-19 Syndrome DOI Open Access
E. A. Sorokina, Alisa Pautova,

Oleg E. Fatuev

et al.

Journal of Personalized Medicine, Journal Year: 2023, Volume and Issue: 13(6), P. 971 - 971

Published: June 8, 2023

Post-COVID-19 syndrome is a complex of different symptoms, which results in multisystemic impairment after the suffering from COVID-19 infection. The aim study was to reveal clinical, laboratory, and gut disorders patients with post-COVID-19 (n = 39) before taking part 14-day program rehabilitation. A complete blood count, coagulation test, chemistry, biomarkers, metabolites serum samples, dysbiosis were revealed on day admission rehabilitation, comparison variables healthy volunteers 48) or reference ranges. On discharge, noted an improvement respiratory function, general well-being, mood. At same time, levels some metabolic (4-hydroxybenzoic, succinic, fumaric acids) inflammatory (interleukin-6) variables, increased admission, did not reach level people during rehabilitation program. Taxonomy disbalance observed patients’ feces, namely, high total bacterial mass, decrease number Lactobacillus spp., increase pro-inflammatory microorganisms. authors suggest that should be personalized, considering patient’s state together only baseline but also individual taxonomy microbiota.

Language: Английский

Citations

9

Follow-up of cognitive impairment and inflammatory profile in individuals with mild COVID-19 DOI
Nathália Gualberto Souza e Silva, Daniela Rosa, Jonas Jardim de Paula

et al.

Journal of Neuroimmunology, Journal Year: 2024, Volume and Issue: 389, P. 578327 - 578327

Published: March 5, 2024

Language: Английский

Citations

3